231 results on '"Momose, Haruka"'
Search Results
2. Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants
3. RAISING is a high-performance method for identifying random transgene integration sites
4. Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations
5. A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo
6. Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection
7. Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile
8. Development of screening method for intranasal influenza vaccine and adjuvant safety in preclinical study
9. Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection
10. Evaluation of marker gene expression as a potential predictive marker of leukopenic toxicity for inactivated influenza vaccines
11. A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests
12. Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice
13. Data from Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma
14. Supplemental Data from Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma
15. Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site
16. Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure
17. Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia
18. Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection
19. Safety and immunogenicity of Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine against SARS-CoV-2 Omicron variant in Japanese healthcare workers
20. Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses
21. Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma
22. RAISING: a high-performance method for identifying random transgene integration sites
23. Application of quantitative gene expression analysis for pertussis vaccine safety control
24. Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation
25. Two vaccine toxicity-related genes Agp and Hpx could prove useful for pertussis vaccine safety control
26. Impact of injection buffer volume to perform bronchoalveolar lavage fluid collection for isolating alveolar macrophages to investigate fine particle-induced IL-1α secretion
27. A semitransparent particulate photoanode composed of SrTiO3 powder anchored on titania nanosheets
28. Degenerate polymerase chain reaction strategy with DNA microarray for detection of multiple and various subtypes of virus during blood screening
29. Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization
30. EVALUATION OF IN VITRO DIAGNOSTIC KITS FOR ANTI-HBs QUANTITATIVE ASSAYS USING THE INTERNATIONAL STANDARD AND JAPANESE NATIONAL STANDARD.
31. Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma
32. Blockage by SP600125 of Fcϵ Receptor-Induced Degranulation and Cytokine Gene Expression in Mast Cells is Mediated Through Inhibition of Phosphatidylinositol 3-Kinase Signalling Pathway
33. 206 The role for interferon regulatory factor-2 on megakaryopoiesis mediated by IFN-γ induction
34. Deficient RPS19 protein production induces cell cycle arrest in erythroid progenitor cells
35. Impact of the SCF signaling pathway on leukemia stem cell mediated ATL initiation and progression in an HBZ transgenic mouse model
36. CALIBRATION OF THE SECOND JAPANESE NATIONAL STANDARD FOR HEPATITIS B IMMUNOGLOBULIN IN A COLLABORATIVE STUDY
37. Establishment of a novel safety assessment method for vaccine adjuvant development
38. Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan
39. REEVALUATION OF THE JAPANESE NATIONAL STANDARDS FOR VIRAL NUCLEIC ACID AMPLIFICATION TESTS (NATs) TO ENSURE SAFETY OF HUMAN BLOOD PRODUCTS
40. Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine
41. Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools
42. In vitro marker gene expression analyses in human peripheral blood mononuclear cells: A tool to assess safety of influenza vaccines in humans
43. Systems biology approach for evaluating vaccine and adjuvant safety during preclinical and lot release testing
44. Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results
45. Isoflurane is a suitable alternative to ether for anesthetizing rats prior to euthanasia for gene expression analysis
46. Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study
47. Identification of ATL stem cells in an ATL model HBZ transgenic mouse
48. Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling
49. Identification of TL-Om1, an Adult T-Cell Leukemia (ATL) Cell Line, as Reference Material for Quantitative PCR for Human T-Lymphotropic Virus 1
50. A New Method for the Evaluation of Vaccine Safety Based on Comprehensive Gene Expression Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.